C. Kearon, E. A. Akl, A. J. Comerota et al., “Antithrom-botic Therapy for Vte Disease. Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, Vol. 141, Suppl. 2, 2012, pp. e419S-e494S.
 K. E. Wood, “Major Pulmonary Embolism. Review of a Pathophysiologic Approach to the Golden Hour on Hemodynamically Significant Pulmonary Embolism,” Chest, Vol. 121, No. 3, 2002, pp. 877-905. doi:10.1378/chest.121.3.877
 L. Daniels, A. Parker, S. R. Patel, F. Grodstein and S. E. Goldhaber, “Relation of Duration of Symptoms with Response to Thrombolytic Therapy in Pulmonary Embolism,” American Journal of Cardiology, Vol. 80, No. 2, 1997, pp. 184-188. doi:10.1016/S0002-9149(97)00315-9